Biopolymer Nanoparticles for Targeted Therapy in Cardiovascular Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 October 2026 | Viewed by 1657
Special Issue Editors
Interests: nanobiotechnology; nanoparticles; multiphoton microscopy; electron microscopy; cell and tissues
Interests: atherosclerosis; epigenetics; epigenomics; cardiovascular therapy; mouse models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology is significantly impacting several areas of biology and pathology. In human health, the development of nanocarriers has improved diagnosis, pharmacology, and therapy. Nanocarriers based on biopolymers, dendrimers, and liposomes have revolutionized the administration of a number of drugs. On the other hand, the mechanisms underlying nanocarrier disassembling and payload deliver within cells remain, in some cases, unclear. Among diseases, cardiovascular disease (CVD) is the first cause of death and disability worldwide, accounting for 17.9 million lost lives yearly. CVD includes various disorders affecting the brain, heart, and blood vessels. This Special Issue will address novel nanopharmacological aspects that can be applied to treat the wide symptoms and causes of CVD. We invite articles on all topics related to the applications of biopolymer nanoparticles and novel drug-loaded nanostructures-based biopolymers applied to the treatment of CVD. This Special Issue focuses on the synthesis, physicochemical characterization, stability, delivery, targeting, and dissembling mechanisms of nanoparticles. In addition, the effect of nanoparticles loaded with drugs can be administrated to cells and tissues for in vitro growth, therapies, imaging diagnosis, and experimental treatments in murine models for CVD are accepted. Clinical studies in humans are accepted. Original research papers and review articles are welcome.
Dr. Lino Sánchez-Segura
Prof. Dr. Silvio Zaina
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- biopolymers
- drug-load
- drug delivery
- target
- cardiovascular disease
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
